| Authors: |
Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Medicine, Korea University, Seoul, Republic of Korea. Electronic address: mdimop@med.uoa.gr., Beksac M; Department of Hematology, Ankara Liv Hospital, Istinye University, Ankara, Turkey., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Delimpasi S; General Hospital Evangelismos, Athens, Greece., Vorobyev V; Leningrad Regional Clinical Hospital, Saint Petersburg, Russian Federation., Quach H; University of Melbourne, St Vincent's Hospital, Melbourne, VIC, Australia., Spicka I; First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Radocha J; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic., Robak P; Medical University of Łódź, Łódź, Poland., Kim K; Department of Medicine, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea., Cavo M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Suzuki K; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Wilkes J; GSK, Stevenage, UK., McNamara S; GSK, Stevenage, UK., Phillips-Jones A; GSK, Stevenage, UK., Morris K; GSK, Durham, NC, USA., Pompilus F; GSK, Philadelphia, PA, USA., Purser M; GSK, Collegeville, PA, USA., Sule N; GSK, Collegeville, PA, USA., Kremer B; GSK, Collegeville, PA, USA., Loubert A; Modus Outcomes, a THREAD Company, Lyon, France., Bunod L; Modus Outcomes, a THREAD Company, Lyon, France., M'Hari M; Modus Outcomes, a THREAD Company, Lyon, France., Zhou XL; GSK, Waltham, MA, USA., Fulci G; GSK, Waltham, MA, USA., Mateos MV; Hematology Department, University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC, Salamanca, Spain., Trudel S; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada. |
